Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders:a review of the literature

References

• Oliveria SA, Felson DT, Reed JI, et al. Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 1995;38:1134–41
   PubMed Web of Science ®Google Scholar
• Brief AA, Maurer SG, Di Cesare PE. Use of glucosamine and chondroitin sulfate in the management of osteoarthritis. J Am Acad Orthop Surg 2001;9:71–8
   PubMedGoogle Scholar
• Moskowitz RW. Role of collagen hydrolysate in bone and joint disease. Semin Arthritis Rheum 2000;30:87–99
   PubMed Web of Science ®Google Scholar
• Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 1988;10:1–28
   PubMed Web of Science ®Google Scholar
• Sharma L, Song J, Felson DT, et al. The role of knee alignment in disease progression and functional decline in knee osteoarthritis. J Am Med Assoc 2001;286:188–95
   PubMed Web of Science ®Google Scholar
• Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000;133: 635–46
   Google Scholar
• Green GA. Understanding NSAIDs: from aspirin to COX-2. Clin Cornerstone 2001;3:50–60
   PubMedGoogle Scholar
• Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health 1994;84:351–8
   PubMed Web of Science ®Google Scholar
• Prevalence of self-reported arthritis or chronic joint symptoms among adults – United States, 2001. MMWR Morb Mortal Wkly Rep 2002;51:948–50
   PubMedGoogle Scholar
• Tesche F, Miosge N. New aspects of the pathogenesis of osteoarthritis: the role of fibroblast-like chondrocytes in late stages of the disease. Histol Histopathol 2005;20:329–37
   PubMed Web of Science ®Google Scholar
• Felson DT, Anderson JJ, Naimark A, et al. Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med 1988;109:18–24
   PubMed Web of Science ®Google Scholar
• Coggon D, Reading I, Croft P, et al. Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord 2001;25:622–7
   PubMed Web of Science ®Google Scholar
• Pearle AD, Warren RF, Rodeo SA. Basic science of articular cartilage and osteoarthritis. Clin Sports Med 2005;24:1–12
   Google Scholar
• Kuettner KE, Aydelotte MB, Thonar EJ. Articular cartilage matrix and structure: a minireview. J Rheumatol Suppl 1991;27:46–8
   Google Scholar
• Buckwalter JA, Mankin HJ. Articular cartilage. Part I: tissue design and chondrocyte-matrix interactions. Instr Course Lect 1998;47:477–86
   PubMedGoogle Scholar
• Linn FC, Sokoloff L. Movement and composition of interstitial fluid of cartilage. Arthritis Rheum 1965;8:481–94
   PubMed Web of Science ®Google Scholar
• Maroudas A, Schneiderman R. ‘Free’ and ‘exchangeable’ or ‘trapped’ and ‘non-exchangeable’ water in cartilage. J Orthop Res 1987;5:133–8
   PubMed Web of Science ®Google Scholar
• Wroble R. Articular cartilage injury and autologous chondrocyte implantation: which patients might benefit? Phys Sports-med 2000;28:43–9
   PubMed Web of Science ®Google Scholar
• Lotz M, Blanco FJ, von Kempis J, et al. Cytokine regulation of chondrocyte functions. J Rheumatol Suppl 1995;43:104–8
   PubMedGoogle Scholar
• Buckwalter JA. Activity vs. rest in the treatment of bone, soft tissue and joint injuries. Iowa Orthop J 1995;15:29–42
   Google Scholar
• Buckwalter JA. Osteoarthritis and articular cartilage use, disuse, and abuse: experimental studies. J Rheumatol Suppl 1995;43:13–5
   PubMedGoogle Scholar
• Gray ML, Pizzanelli AM, Grodzinsky AJ, Lee RC. Mechanical and physiochemical determinants of the chondrocyte bio-synthetic response. J Orthop Res 1988;6:777–92
   PubMed Web of Science ®Google Scholar
• McAlindon TE, Jacques P, Zhang Y, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum 1996;39:648–56
   PubMed Web of Science ®Google Scholar
• Hadler NM, Gillings DB, Imbus HR, et al. Hand structure and function in an industrial setting. Arthritis Rheum 1978;21: 210–20
   PubMed Web of Science ®Google Scholar
• Trippel SB. Growth factor actions on articular cartilage. J Rheumatol Suppl 1995;43:129–32
   PubMedGoogle Scholar
• Trippel SB, Corvol MT, Dumontier MF, et al. Effect of somatomedin-C/insulin-like growth factor I and growth hormone on cultured growth plate and articular chondrocytes. Pediatr Res 1989;25:76–82
   PubMed Web of Science ®Google Scholar
• Lum ZP, Hakala BE, Mort JS, Recklies AD. Modulation of the catabolic effects of interleukin-1 beta on human articular chondrocytes by transforming growth factor-beta. J Cell Physiol 1996;166:351–9
   PubMed Web of Science ®Google Scholar
• Inoue H, Kato Y, Iwamoto M, et al. Stimulation of cartilage-matrix proteoglycan synthesis by morphologically transformed chondrocytes grown in the presence of fibroblast growth factor and transforming growth factor-beta. J Cell Physiol 1989;138:329–37
   PubMed Web of Science ®Google Scholar
• Morales TI. Transforming growth factor-beta and insulin-like growth factor-1 restore proteoglycan metabolism of bovine articular cartilage after depletion by retinoic acid. Arch Biochem Biophys 1994;315:190–8
   PubMed Web of Science ®Google Scholar
• Martin JA, Buckwalter JA. Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 2002;3: 257–64
   PubMed Web of Science ®Google Scholar
• Koepp H, Eger W, Muehleman C, et al. Prevalence of articular cartilage degeneration in the ankle and knee joints of human organ donors. J Orthop Sci 1999;4:407–12
   PubMedGoogle Scholar
• Buckwalter JA, Lappin DR. The disproportionate impact of chronic arthralgia and arthritis among women. Clin Orthop Relat Res 2000:159–68
   PubMed Web of Science ®Google Scholar
• Buckwalter J, Goldberg V, Woo S-Y. Musculoskeletal soft-tissue aging: impact on mobility. Rosemont (IL): American Academy of Orthopedic Surgeons; 1993
   Google Scholar
• DeGroot J, Verzijl N, Bank RA, et al. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation. Arthritis Rheum 1999;42:1003–9
   PubMed Web of Science ®Google Scholar
• Verzijl N, DeGroot J, Oldehinkel E, et al. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J 2000;350:381–7
   PubMed Web of Science ®Google Scholar
• Brandt KD. Osteoarthritis. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s principles of internal medicine, 15th ed. New York: McGraw-Hill; 2001
   Google Scholar
• Felson DT, Hannan MT, Naimark A, et al. Occupational physical demands, knee bending, and knee osteoarthritis: results from the Framingham Study. J Rheumatol 1991;18:1587–92
   PubMed Web of Science ®Google Scholar
• Buckwalter JA, Lane NE. Athletics and osteoarthritis. Am J Sports Med 1997;25:873–81
   PubMed Web of Science ®Google Scholar
• Cushnaghan J, Dieppe P. Study of 500 patients with limb joint osteoarthritis. I. Analysis by age, sex, and distribution of symptomatic joint sites. Ann Rheum Dis 1991;50:8–13
   Google Scholar
• Dieppe P. Osteoarthritis: clinical and research perspective. Br J Rheumatol 1991;30(Suppl 1):1–4
   Google Scholar
• Felson DT. Osteoarthritis. Rheum Dis Clin North Am 1990;16:499–512
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee [American College of Rheumatology]. Arthritis Rheum 1995;38:1541–6
   PubMed Web of Science ®Google Scholar
• American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905–15
   PubMed Web of Science ®Google Scholar
• Towheed TE, Judd MJ, Hochberg MC, Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2003:CD004257
   Google Scholar
• Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006:CD004257
   Google Scholar
• Hylek EM, Heiman H, Skates SJ, et al. Acetaminophen and other risk factors for excessive warfarin anticoagulation. J Am Med Assoc 1998;279:657–62
   PubMed Web of Science ®Google Scholar
• Lazzaroni M, Bianchi Porro G. Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations. Aliment Pharmacol Ther 2004;20(Suppl 2): 48–58
   PubMedGoogle Scholar
• Garner SE, Fidan DD, Frankish RR, et al. Rofecoxib for rheumatoid arthritis. Cochrane Database Syst Rev 2005: CD003685
   Google Scholar
• Anon. Annual nutrition industry overview. Nutrition Business J 2005;10:6–7
   Google Scholar
• McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. J Am Med Assoc 2000;283:1469–75
   PubMed Web of Science ®Google Scholar
• Ronca F, Palmieri L, Panicucci P, Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 1998;6(Suppl A):14–21
   Google Scholar
• Setnikar I, Giacchetti C, Zanolo G. Pharmacokinetics of glucosamine in the dog and in man. Arzneimittelforschung 1986;36:729–35
   PubMed Web of Science ®Google Scholar
• Bassleer C, Henrotin Y, Franchimont P. In-vitro evaluation of drugs proposed as chondroprotective agents. Int J Tissue React 1992;14:231–41
   PubMedGoogle Scholar
• Vidal y Plana RR, Bizzarri D, Rovati AL. Articular cartilage pharmacology: I. In vitro studies on glucosamine and non steroidal antiinflammatory drugs. Pharmacol Res Commun 1978;10:557–69
   Google Scholar
• McCarty MF. Enhanced synovial production of hyaluronic acid may explain rapid clinical response to high-dose glucosamine in osteoarthritis. Med Hypotheses 1998;50:507–10
   PubMed Web of Science ®Google Scholar
• Balkan B, Dunning BE. Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats. Diabetes 1994;43:1173–9
   PubMed Web of Science ®Google Scholar
• Patti ME, Virkamaki A, Landaker EJ, et al. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 1999;48:1562–71
   PubMed Web of Science ®Google Scholar
• Shankar RR, Zhu JS, Baron AD. Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus. Metabolism 1998;47:573–7
   Google Scholar
• Biggee BA, McAlindon T. Glucosamine for osteoarthritis: part II, biologic and metabolic controversies. Med Health R I 2004;87:180–1
   PubMedGoogle Scholar
• Scroggie DA, Albright A, Harris MD. The effect of glucosaminechondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Arch Intern Med 2003;163: 1587–90
   Google Scholar
• Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. New Engl J Med 2006;354:795–808
   PubMed Web of Science ®Google Scholar
• Biggee BA, McAlindon T. Glucosamine for osteoarthritis: part I, review of the clinical evidence. Med Health R I 2004;87:176–9
   PubMedGoogle Scholar
• McAlindon T. Why are clinical trials of glucosamine no longer uniformly positive? Rheum Dis Clin North Am 2003;29:789–801
   PubMed Web of Science ®Google Scholar
• Kim LS, Axelrod LJ, Howard P, et al. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage 2006;14: 286–94
   PubMed Web of Science ®Google Scholar
• Harmand MF, Vilamitjana J, Maloche E, et al. Effects of S-adenosylmethionine on human articular chondrocyte differentiation. An in vitro study. Am J Med 1987;83(Suppl 5A):48–53
   Google Scholar
• Oesser S, Seifert J. Stimulation of type II collagen biosynthesis and secretion in bovine chondrocytes cultured with degraded collagen. Cell Tissue Res 2003;311:393–9
   PubMed Web of Science ®Google Scholar
• Data on file, GELITA Health Products, Vernon Hills, Illinois 2006
   Google Scholar
• Krug E. Zur unterstützenden Therapie bei Osteo- und Chondropathien. Z Erfahrungsheikunde 1979;11:930–8
   Google Scholar
• Götz B. Gut genährter Knorpel knirscht nicht mehr. Ärztl Prax 1982;92:3130–4
   Google Scholar
• Oberschelp U. Individuelle Arthrosetherapie ist möglich. Therapiewoche 1985;44:5094–7
   Google Scholar
• Adam M. Welche Wirkung haben Gelatinepräparate? Ther Osteoarthrose Therapiewoche 1991;41:2456–61
   Google Scholar
• Flechsenhar K, Alf D. Ergebnisse einer Anwendungsbeobachtung zu Kollagen-Hydrolysat CH-Alpha. Orthopaedische Praxis 2005;9:486–94
   Google Scholar
• Zukley L, Angelopoulos K, Carpenter M, et al. Collagen hydrolysate improves joint function in adults with mild symptoms of osteoarthritis of the knee. 51st Annual American College of Sports Medicine 2004 [poster]
   Google Scholar
• Oesser S, Adam M, Babel W, Seifert J. Oral administration of (14)C labeled gelatin hydrolysate leads to an accumulation of radioactivity in cartilage of mice (C57/BL). J Nutr 1999;129:1891–5
   PubMed Web of Science ®Google Scholar
• Oesser S. Degraded collagen modulates the internal remodeling of cartilage extracellular matrix. Arthritis Rheum 2005;52(Suppl 9):S62
   Web of Science ®Google Scholar
• Zuckley L, Angelopoulou K, Carpenter MR, et al. Collagen hydrolysate improves joint function in adults with mild symptoms of osteoarthritis of the knee. Med Sci Sports Exerc 2004;36(Suppl):S153–S154
   Google Scholar
• Selbmann H-K, Fischer IU, Moskowitz RW. Collagen hydrolysate in knee osteoarthritis (OA): population specific responses. Poster at The Congress of the Osteoarthritis Research Society International (OARSI) 2004
   Google Scholar